Hongfei W. Jiang

Guangxi Key Laboratory Of Special Biomedicine
Nanning, 530004, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 64 publications

Design and engineering of μO-conotoxin MfVIA mutants to enhance NaV1.8 inhibition and analgesic efficacy in inflammatory pain.

Design and engineering of μO-conotoxin MfVIA mutants to enhance NaV1.8 inhibition and analgesic efficacy in inflammatory pain.

Journal: Bioorganic & medicinal chemistry

Published: March 05, 2026

Design, synthesis, and biological evaluation of novel 3-aryl-4-(3,4,5-trimethoxyphenyl)selenophene derivatives as new tubulin inhibitors.

Design, synthesis, and biological evaluation of novel 3-aryl-4-(3,4,5-trimethoxyphenyl)selenophene derivatives as new tubulin inhibitors.

Journal: Journal of enzyme inhibition and medicinal chemistry

Published: December 01, 2025

Editorial: The application of immune checkpoint inhibitors combined with chemotherapy in tumor immunotherapy.

Editorial: The application of immune checkpoint inhibitors combined with chemotherapy in tumor immunotherapy.

Journal: Frontiers in immunology

Published: October 31, 2025

Maritoclax Overcomes FBW7 Deficiency-Driven Irinotecan Resistance in Colorectal Cancer by Targeting MCL1.

Maritoclax Overcomes FBW7 Deficiency-Driven Irinotecan Resistance in Colorectal Cancer by Targeting MCL1.

Journal: Cancer medicine

Published: July 28, 2025

Corrigendum to "Hypoxia-selective prodrug restrains tumor cells through triggering mitophagy and inducing apoptosis" [Europ. J. Med. Chem. 283 (2025) 17155].

Corrigendum to "Hypoxia-selective prodrug restrains tumor cells through triggering mitophagy and inducing apoptosis" [Europ. J. Med. Chem. 283 (2025) 17155].

Journal: European journal of medicinal chemistry

Published: June 20, 2025

Immune surveillance as a pharmacological target in the early stages of cancer.

Immune surveillance as a pharmacological target in the early stages of cancer.

Journal: Frontiers in molecular biosciences

Published: June 07, 2025

CLOCK promotes proliferation of glioblastoma cells through acetylating PRPS1/2.

CLOCK promotes proliferation of glioblastoma cells through acetylating PRPS1/2.

Journal: Journal of neuro-oncology

Published: April 15, 2025

Nucleus-translocated glucokinase functions as a protein kinase to phosphorylate TAZ and promote tumour growth.

Nucleus-translocated glucokinase functions as a protein kinase to phosphorylate TAZ and promote tumour growth.

Journal: Nature communications

Published: February 27, 2025

Correction: Camptothecin-based prodrug nanomedicines for cancer therapy.

Correction: Camptothecin-based prodrug nanomedicines for cancer therapy.

Journal: Nanoscale

Published: January 09, 2025

Corrigendum: Pyroglutamyl aminopeptidase 1 is a potential molecular target toward diagnosing and treating inflammation.

Corrigendum: Pyroglutamyl aminopeptidase 1 is a potential molecular target toward diagnosing and treating inflammation.

Journal: Frontiers in immunology

Published: December 03, 2024

The potential of ARL4C and its-mediated genes in atherosclerosis and agent development.

The potential of ARL4C and its-mediated genes in atherosclerosis and agent development.

Journal: Frontiers in pharmacology

Published: October 26, 2024

Hypoxia-selective prodrug restrains tumor cells through triggering mitophagy and inducing apoptosis.

Hypoxia-selective prodrug restrains tumor cells through triggering mitophagy and inducing apoptosis.

Journal: European journal of medicinal chemistry

Published: September 11, 2024

Showing 1-12 of 64

Last Updated: 09/26/2026